期刊文献+

肺炎衣原体感染与冠心病的相关性研究 被引量:4

Correlation of Chlamydia Pneumoniae Infection with Coronary Heart Disease
暂未订购
导出
摘要 目的:通过测定血清肺炎衣原体(TWAR)IgG、IgM抗体滴度水平,探讨肺炎衣原体感染与冠心病的相关性。    方法:应用间接微量免疫荧光法,测定115例冠心病病人(冠心病组)和60例健康人(正常对照组)血清肺炎衣原体IgG、IgM抗体滴度。    结果:冠心病组病人血清肺炎衣原体IgG平均几何滴度(GMT)(1∶57.77±4.42)与正常对照组(1∶19.93±4.29)相比有非常显著性差异(P<0.001)。冠心病组肺炎衣原体既往感染阳性率明显高于正常对照组(70.4%vs 36.7%,P<0.001),2组急性感染阳性率无明显差异(P>0.05)。随着肺炎衣原体IgG抗体水平(IgG≥1∶16)的增高,发生冠心病风险相对增高(OR 4.36,95%CI 2.32~8.16)。不稳定性心绞痛病人、急性心肌梗塞病人血清肺炎衣原体IgG平均几何滴度及感染阳性率均无明显差别,但两者与正常对照组相比均有非常显著性差异(P<0.001)。    结论:研究结果表明,冠心病组病人肺炎衣原体感染率及血清肺炎衣原体IgG平均几何滴度均较高,有抗体者(IgG≥1∶16)发生冠心病的风险相对增加,肺炎衣原体感染可能是构成? Objective:To evaluate the association between chlamydia pneumoniae infection and coronary heart disease. Methods:TWAR IgG,IgM antibodies were measured by microimmuno fluorescence test on admission in 115 patients with coronary heart disease(CHD)and 60 subjects without CHD. Results:Geometric mean IgG titre(IgG GMT)was significantly higher in patients with CHD(1:57.77±4.42,p<0.001)compared with the controls(1:19.93±4.29,p<0.001).The frepuency of chronic infection was sig nificantly higher in CHD group than in the controls (70.4% vs.36.7%,p<0.001).No significant difference of acute infection(p>0.05)was found between both groups.Higher TWAR IgG antibody titres(IgG≥1:16)were associated with increased risk of CHD(OR 4.36,95% CI 2.32-8.16) Conclusions:There are higher chronic Chlamydia pneumoniae infection rate and TWAR IgG GMT in CHD.Higher TWAR IgG antibody titers are associated with increased risk of CHD.Chronic chlamydia pneumoniae infection may be a risk factor for the developing of CHD.
出处 《中国循环杂志》 CSCD 北大核心 2001年第4期279-281,共3页 Chinese Circulation Journal
基金 卫生部科研基金项目(1998BA1CBB1)
关键词 冠心病 肺炎衣原体感染 相关性研究 Chlamydia pneumoniae Antibody Coronary heart disease
  • 相关文献

参考文献1

二级参考文献2

  • 1倪安平,中华医学杂志,1994年,74卷,416页
  • 2Wang S P,J Clin Microbiol,1979年,10卷,259页

共引文献44

同被引文献34

  • 1李涛,许香广,张国良,黄建平,张明,方卫华,李松,张旭.冠心病与肺炎衣原体感染的关系及治疗探讨[J].现代预防医学,2004,31(5):679-680. 被引量:2
  • 2[1]Saikku P, Leinonen M, Mattila K J, et al. Serological evidence of an association of novel chlamydial, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1998; 29: 983-985.
  • 3[2]Danesh J, Collins R, Peto R. Infection and coronary heart disease: is there a link? Lancet 1997; 350:430-36.
  • 4[3]Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
  • 5[4]Toss H, Gnarpe J, Gnarpe H, et al. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J 1998; 19 (4) :570-7.
  • 6[5]Rothstein NM, Quinn TC, Madico G, et al. Effect of azithromycin on murine arteriosclerosis exacerbated by chylamydia pneumoniae. J Infect Dis 2001; 183:232-8.
  • 7[6]Ericson K, Salden GP, Lindquist O, et al. Relationship of chlamydia pnemoniae infection to severity of human coronary atherosclerosis. Circulation 2000; 101:2568-2571.
  • 8[7]Neumann FJ, Kastrati A, Miethke T, et al. Treatment of chlamydia pneurmoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebocontrolled trial. Lancet 2001; 357:2085-89.
  • 9[8]Muhlestein JB, Anderson JL, Carlquist JF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 2000; 102 (15) :1755-60.
  • 10[9]Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study group. Lancet 1997; 350(9075) :404-7.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部